In 2017, Fishbein et al. found CSDE1 loss-of-function mutations as drivers of neuroendocrine tumors with a Wnt-altered phenotype, indicating that CSDE1 is a suppressor of this tumor type (48). This evidence concerns the gene CSDE1 and neoplasm.